Floatz logo

GLYCERIN,ANHYDROUS

Metabolic Syndrome X

Radboud University Medical CenterSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Metabolic Syndrome X cohort.

Asset / SponsorPhaseRating
Topamax
All India Institute of Medical Sciences, Bhubaneswar
Phase 4BBB
Cilnidipine
Boryung Pharmaceutical Co., Ltd
Phase 4BB
TAMOXIFEN
Veterans Medical Research Foundation
Phase 4BB
EXEMESTANE
Veterans Medical Research Foundation
Phase 4BB
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
Korea University Anam Hospital
Phase 4BB

View all 25 →

Same molecule, other indications

GLYCERIN,ANHYDROUS is also rated in:

Obesity, VisceralDormant
BB
Indicative ·
69 / 100
View asset →
Low Anterior Resection SyndromeDormant
B
Indicative ·
60 / 100
View asset →
rectal carcinomaDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →